|
Model Number RXM1000 |
Device Problem
Application Program Problem: Dose Calculation Error (1189)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 11/17/2021 |
Event Type
malfunction
|
Manufacturer Narrative
|
Reflexion has investigated the issue and determined the cause to be a code implementation defect in the treatment planning software.When reflexion's treatment planning system calculates dose, an accurate orientation for image, dose, primary beam, and scatter orientation (dose angles) is necessary.The scatter orientation in the dose calculation algorithm is incorrect for any patient orientation other than head first supine (hfs).The other patient orientations are head first prone (hfp), feet first prone (ffp), and feet first supine (ffs).Treatment plans for hfs are not affected.
|
|
Event Description
|
Patient (b)(6) received 15 out of 25 planned fractions for prostate bed + lymph node on the reflexion x1 system.During the initial 15 fractions on x1, the patient received an overdose of 9.6% to the planning target volume (ptv) due to a defect in the treatment planning software dose calculation.After the issue was identified, he received the rest of his treatment on another radiotherapy device, with the treating radiation oncologist deciding to drop some of the remaining fractions to compensate.The actual final delivered prescription dose amounted to a 1.25% underdose, which still meets clinical treatment goals.The final, aggregate delivered dose to all organs at risk still fell within acceptable tolerance dose limits.There is no expectation that the final dose distribution would cause excess risk of harm beyond the baseline level of risk of prostate bed radiotherapy.Additionally, the increase in the risk of secondary malignancy is minimal in this scenario.
|
|
Search Alerts/Recalls
|
|
|